Cargando…

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Ixodes scapularis on dogs

BACKGROUND: The black-legged (or deer) tick, Ixodes scapularis, commonly infests dogs and cats in North America and is the main vector for the pathogen that causes Lyme disease in dogs and humans. The speed of kill of a parasiticide is critical to minimize the direct and deleterious effects of tick...

Descripción completa

Detalles Bibliográficos
Autores principales:	Six, Robert H., Young, David R., Myers, Melanie R., Mahabir, Sean P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753652/ https://www.ncbi.nlm.nih.gov/pubmed/26876891 http://dx.doi.org/10.1186/s13071-016-1307-x

Ejemplares similares

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill of sarolaner (Simparica(®)) and afoxolaner (NexGard(®)) against induced infestations of Ixodes holocyclus on dogs
por: Packianathan, Raj, et al.
Publicado: (2017)

Comparative speed of kill of sarolaner (Simparica™) and afoxolaner (NexGard®) against induced infestations of Rhipicephalus sanguineus s.l. on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra(®)) against induced infestations of Ixodes holocyclus in dogs
por: Packianathan, Raj, et al.
Publicado: (2020)

Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGard(TM)) against induced infestations with Ixodes ricinus ticks
por: Halos, Lénaïg, et al.
Publicado: (2014)

Treatment of canine sarcoptic mange with afoxolaner (NexGard(®)) and afoxolaner plus milbemycin oxime (NexGard Spectra(®)) chewable tablets: efficacy under field conditions in Portugal and Germany
por: Hampel, Verena, et al.
Publicado: (2018)

Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe
por: Lebon, Wilfried, et al.
Publicado: (2018)

Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions
por: Mihalca, Andrei Daniel, et al.
Publicado: (2022)

Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard(®)
por: Liebenberg, Julian, et al.
Publicado: (2017)

Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae)
por: Alfonso Mendoza-Roldan, Jairo, et al.
Publicado: (2023)

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of Ixodes scapularis on dogs
por: Holzmer, Susan, et al.
Publicado: (2020)

Comparative speed of kill of sarolaner (Simparica(™)) and fluralaner (Bravecto(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill of sarolaner (Simparica(™)) and spinosad plus milbemycin oxime (Trifexis(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill after treatment with Simparica(™)(sarolaner) and Advantix(®)(imidacloprid + permethrin) against induced infestations of Dermacentor reticulatus on dogs
por: Becskei, Csilla, et al.
Publicado: (2016)

Comparative speed of kill of oral treatments with Simparica(TM)(sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs
por: Becskei, Csilla, et al.
Publicado: (2016)

Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area
por: Panarese, Rossella, et al.
Publicado: (2021)

Efficacy of sarolaner (Simparica(®)) against induced infestations of Haemaphysalis longicornis on dogs
por: Oda, Kenji, et al.
Publicado: (2019)

Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs
por: Geurden, Thomas, et al.
Publicado: (2017)

NexGard(®) Combo (esafoxolaner, eprinomectin, praziquantel), a new endectoparasiticide spot-on formulation for cats
por: Beugnet, Frederic
Publicado: (2021)

Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs
por: Jongejan, Frans, et al.
Publicado: (2016)

Preventive efficacy of NexGard Spectra(®) against Dipylidium caninum infection in dogs using a natural flea (Ctenocephalides felis) infestation model
por: Beugnet, Frédéric, et al.
Publicado: (2017)

Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®
por: Abbate, Jessica M., et al.
Publicado: (2018)

Efficacy and safety of sarolaner (Simparica(®)) in the treatment and control of naturally occurring flea infestations in dogs presented as veterinary patients in Australia
por: Packianathan, Raj, et al.
Publicado: (2017)

Immediate and persistent efficacy of sarolaner (Simparica™) against Haemaphysalis elliptica on dogs
por: Fourie, Josephus J., et al.
Publicado: (2019)

Efficacy of a topical formulation containing esafoxolaner, eprinomectin and praziquantel (NexGard Combo(®)) against natural infestations with the cat louse, Felicola subrostratus under field conditions
por: Mihalca, Andrei Daniel, et al.
Publicado: (2022)

Safety of Simparica Trio(®) (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs
por: Mathur, Sheerin, et al.
Publicado: (2023)

Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against four common tick species infesting dogs in Europe
por: Becskei, Csilla, et al.
Publicado: (2020)

Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio(®)) in the treatment of sarcoptic mange caused by Sarcoptes scabiei mite infestations in dogs
por: Becskei, Csilla, et al.
Publicado: (2023)

Comparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto(®) Chew (25 mg/kg fluralaner) or Simparica TRIO(®) (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel)
por: Reif, Kathryn E., et al.
Publicado: (2023)

Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of five common tick species infesting dogs in the USA
por: Kryda, Kristina, et al.
Publicado: (2020)

Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA
por: Kryda, Kristina, et al.
Publicado: (2020)

Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe
por: Becskei, Csilla, et al.
Publicado: (2020)

Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio™) for the prevention of experimental Angiostrongylus vasorum infection in dogs
por: Becskei, Csilla, et al.
Publicado: (2020)

Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) for the treatment and control of flea infestations on dogs
por: Kryda, Kristina, et al.
Publicado: (2020)

Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio(®)) for the prevention of Thelazia callipaeda canine eyeworm infection
por: Bezerra-Santos, Marcos Antonio, et al.
Publicado: (2022)

Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs
por: Becskei, Csilla, et al.
Publicado: (2020)

Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio(®)) for the prevention of angiostrongylosis in dogs presented as veterinary patients
por: Becskei, Csilla, et al.
Publicado: (2020)

Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced ascarid infections in dogs
por: Becskei, Csilla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1fs42segv9bo41lgrcff621ba1